SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-036320
Filing Date
2021-05-27
Accepted
2021-05-27 18:06:16
Documents
2
Period of Report
2021-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3955
2 POA DOCUMENT poa.txt EX-24.3_988681 4705
  Complete submission text file 0001209191-21-036320.txt   10130
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Issuer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address
Leavitt Chase C. (Reporting) CIK: 0001777467 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50549 | Film No.: 21974752